| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $22K | — |
| Cost of Revenue | $4K | — |
| Gross Profit | $18K | — |
| R&D Expense | $2.1M | +323.5% |
| SG&A Expense | $6.8M | +163.2% |
| Operating Income | -$8.9M | -188.2% |
| Net Income | -$8.6M | -254.4% |
| EPS (Basic) | -$0.25 | -212.5% |
| EPS (Diluted) | -$0.25 | -212.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $3K | — |
| Inventory | $160K | — |
| Current Assets | $4.8M | +3.8% |
| Total Assets | $5.6M | -10.3% |
| Current Liabilities | $7.4M | +268.1% |
| Total Liabilities | $7.4M | +264.3% |
| Stockholders' Equity | -$1.8M | -143.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.4M | -38.4% |
| Financing Cash Flow | $5.4M | -29.0% |